Marinus Pharmaceuticals
Why Robinhood?
You can watch MRNS and buy or sell other stocks, ETFs, and their options commission-free!About MRNS
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid.
MRNS Key Statistics
Stock Snapshot
With a market cap of 29.63M, Marinus Pharmaceuticals(MRNS) trades at $0.55. The stock has a price-to-earnings ratio of -0.22.
Marinus Pharmaceuticals(MRNS) stock opened on 2026-05-06 at —. The price climbed to — and dipped to —.
Marinus Pharmaceuticals(MRNS) shares are trading with a volume of 0, against a daily average of 333.56K.
During the past year, Marinus Pharmaceuticals(MRNS) stock moved between $0.22 at its lowest and $10.50 at its peak.
During the past year, Marinus Pharmaceuticals(MRNS) stock moved between $0.22 at its lowest and $10.50 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.